Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027494 · ClinicalTrials.gov registry record
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 318
- Enrollment target
NCT01027494: Completed study, sponsored by Alcon Research.
NCT01027494 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 318 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01027494 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 318 participants
- Enrollment target
Study Summary
The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat.
Interventions
- DRUG Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-11 |
What the finished NCT01027494 record still lists
NCT01027494 is an observational study that tracks outcomes without assigning an intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is the first listed.
NCT01027494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01027494 about?
NCT01027494 is a clinical study titled "Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora". The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat.
What is the current status of trial NCT01027494?
This trial is currently completed. The enrollment target is 318 participants. The study started on 2009-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01027494?
The interventions under investigation include: Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension (DRUG).
Who is sponsoring clinical trial NCT01027494?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia